ProPhase Labs, Inc.·4

Mar 19, 9:48 PM ET

Karkus Ted William 4

4 · ProPhase Labs, Inc. · Filed Mar 19, 2024

Insider Transaction Report

Form 4
Period: 2024-03-17
Transactions
  • Award

    Option (right to buy)

    2024-03-17400,000400,000 total
    Exercise: $6.00Exp: 2031-03-17Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary